Arena-Eisai obesity drug receives FDA approval
The FDA approved Belviq as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.
The collaboration will focus on addressing the drug delivery challenges of poorly soluble molecules with limited oral bioavailability by integrating Quotient’s RapidFACTTM clinical manufacture and testing service with